You are using an outdated browser. Please upgrade your browser to improve your experience.

Bruton-type agammaglobulinemia

Disease Summary
Associated Targets (9)
Tbio

8

Tclin

1


GARD Rare
Mondo Description X-linked agammaglobulinemia (XLA) is a clinically variable form of isolated agammaglobulinemia, an inherited immunodeficiency disorder, and is characterized in affected males by recurrent bacterial infections during infancy.
Uniprot Description Humoral immunodeficiency disease which results in developmental defects in the maturation pathway of B-cells. Affected boys have normal levels of pre-B-cells in their bone marrow but virtually no circulating mature B-lymphocytes. This results in a lack of immunoglobulins of all classes and leads to recurrent bacterial infections like otitis, conjunctivitis, dermatitis, sinusitis in the first few years of life, or even some patients present overwhelming sepsis or meningitis, resulting in death in a few hours. Treatment in most cases is by infusion of intravenous immunoglobulin.
Disease Ontology Description A B cell deficiency that is that has material basis in a mutation in the Bruton's tyrosine kinase (BTK) gene on the X chromosome resulting in X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement.
Mondo Term and Equivalent IDs
MONDO:0010421:  Bruton-type agammaglobulinemia
GARD:0001033: 
MESH:C537409: 
NCIT:C3822: 
Orphanet:47: 
SCTID:65880007: 
UMLS:C0221026: